Montana 2025 Regular Session

Montana Senate Bill SB461

Introduced
2/24/25  
Refer
2/25/25  
Engrossed
3/7/25  
Refer
3/17/25  

Caption

Generally revise administration of drug and substance laws

Impact

If enacted, SB 461 will directly impact state laws by introducing a framework for the sale and distribution of kratom, as well as redefining the oversight responsibilities of the Department of Revenue regarding hemp products. The bill empowers the state to impose penalties on violators and sets standards for the content of kratom products, potentially reducing the risks associated with unregulated consumption. This shift could lead to increased safety for consumers but may also alter the market dynamics for kratom sellers.

Summary

Senate Bill 461, known as the Kratom Consumer Protection Act, aims to regulate the sale and distribution of kratom products in Montana. The bill prohibits the sale of kratom products to individuals under 21 years of age and establishes regulations for kratom processors, defining specific criteria for acceptable kratom products. The intent is to prevent the sale of contaminated or synthesized kratom substances and to protect consumers while addressing public health concerns related to unregulated kratom products.

Sentiment

Discussions surrounding SB 461 reflect a mixed sentiment. Proponents argue that the bill enhances consumer safety and creates a controlled environment for the sales of kratom, which helps to address public health issues. However, critics express concerns that the regulations may enforce overly strict limitations on kratom sales, which could hinder access to products for legitimate users. The tension between safety and accessibility is evident in the legislative discourse.

Contention

Notable points of contention include the thresholds set for permissible levels of alkaloids in kratom products and the prohibition of synthesized materials. Some stakeholders suggest that these restrictions may stifle innovation within the kratom market, while supporters believe they are essential for consumer safety. The debate emphasizes the challenge of balancing regulation with fair market access, and additional amendments may arise as the discussion continues.

Companion Bills

No companion bills found.

Previously Filed As

MT S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

MT A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

MT S2271

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.

MT A1203

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.

MT HB968

Controlled substances; mitragynine and hydroxymitragynine (7-OH) are Schedule I; provide

MT SB1868

Relating to adding certain substances to the Texas Controlled Substances Act and regulating kratom and kratom products; increasing civil penalties; creating criminal offenses; increasing a criminal penalty.

MT SB262

An Act To Amend Title 16 Of The Delaware Code Relating To The Uniform Controlled Substances Act.

MT HB291

Relating to adding certain substances to the Texas Controlled Substances Act and regulating kratom and kratom products; increasing civil penalties; creating criminal offenses; increasing a criminal penalty.

MT A1636

Classifies 7 Hydroxymitragynine as Schedule I drug and bans sale of products containing substance.

MT SB497

Adding kratom to schedule I of the uniform controlled substances act and making conforming amendments to the definition of fentanyl-related controlled substance in the criminal code.

Similar Bills

AZ SB1641

Marijuana producers; licensure

AZ SB1713

Marijuana; dual licensees; rural communities

AZ HB2179

Marijuana; advertising; restrictions

AZ SB1057

Marijuana; rural opportunity initiative

AZ SB1105

Medical marijuana dispensaries; location